Latest filing published 15 Mar 2022 for Chemomab Therapeutics Ltd., €2,542.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -63.7%Entry US$16.76 · Close at T+365 US$6.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Dale R. Pfost: trading record in brief
Dale R. Pfost, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Chemomab Therapeutics Ltd. and Opko Health, Inc. Between 29 March 2007 and 14 March 2022, the trades on record add up to 3 filings.
Every open-market trade on record is a purchase: 2 purchases worth €9,095, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2022: 2 purchases and no sales on the market.
The record was last updated on 15 March 2022 with an open-market purchase (€2,542) in Chemomab Therapeutics Ltd. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Dale R. Pfost
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 700 shares@ US$3.9727.9% of flowAmerican Depositary SharesSEC:0001178913-22-001120:1Canonical exit: 12 Jun 2022 (T+90)
- 1,800 shares@ US$3.98100.0% of flowAmerican Depositary SharesSEC:0001178913-22-001120:0Canonical exit: 12 Jun 2022 (T+90)
- 1,687,261 shares0Common Stock, par value $.01 per shareSEC:0001192482-07-000139:0
3 of 3 declarations
